MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Harvard University · Dana-Farber Cancer Institute · +5 more institutions
Abstract
Waldenström's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated.
We performed whole-genome sequencing of bone marrow LPL cells in 30 patients with Waldenström's macroglobulinemia, with paired normal-tissue and tumor-tissue sequencing in 10 patients. Sanger sequencing was used to validate the findings in samples from an expanded cohort of patients with LPL, those with other B-cell disorders that have some of the same features as LPL, and healthy donors.
Citation impact
- FWCI
- 41.19
- Percentile
- 100%
- References
- 36
Authors
19- SPSteven P. TreonCorresponding
Harvard University, Dana-Farber Cancer Institute
- LXLian Xu
Harvard University, Dana-Farber Cancer Institute
- GYGuang Yang
Harvard University, Dana-Farber Cancer Institute
- YZYangsheng Zhou
Harvard University, Dana-Farber Cancer Institute
- XLXia Liu
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
- Waldenstrom macroglobulinemia
- Macroglobulinemia
- Lymphoplasmacytic Lymphoma
- Medicine
- Gammopathy
- Immunoglobulin M
- Sanger sequencing
- Bone marrow
- Good health and well-being